Canine hepacivirus is not associated with chronic liver disease in dogs

Journal of Viral Hepatitis

Volumn 21, Issue 3, 2014, Pages 223-228

  Bexfield, Nicholas H ^a   Watson, P J ^a   Heaney, J ^a   Heeney, J L ^a   Tiley, L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

aetiology; dog; hepatitis; respiratory; RNA virus

Indexed keywords

HELICASE; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL TISSUE; ARTICLE; CANINE HEPACIVIRUS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; EXPERIMENTAL DOG; HEPATITIS C VIRUS; HETEROZYGOTE; HISTOPATHOLOGY; IMMUNOPRECIPITATION; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS GENOME;

AETIOLOGY; DOG; HEPATITIS; RESPIRATORY; RNA VIRUS;

ANIMALS; DOG DISEASES; DOGS; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; LIVER DISEASES; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84892825986     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12150     Document Type: Article

References (40)

1. Kapoor A, Simmonds P, Gerold G, et al,. Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A 2011; 108 (28): 11608-11613.
2. Bukh J, Hepatitis C, homolog in dogs with respiratory illness. Proc Natl Acad Sci USA 2011; 108 (31): 12563-12564.
3. WHO, Hepatitis C,. Surveillance and Control. Fact sheet N°164: World Health Organization, Switzerland, 2012.
4. Bukh J, Meuleman P, Tellier R, et al,. Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models. J Infect Dis 2010; 201 (9): 1381-1389.
5. Lindenbach BD, Evans MJ, Syder AJ, et al,. Complete replication of hepatitis C virus in cell culture. Science 2005; 309 (5734): 623-626.
6. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R,. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285 (5424): 110-113.
7. Dolgin E,. Research technique: the murine candidate. Nature 2011; 474 (7350): S14-S15.
8. Murray CL, Rice CM,. Turning hepatitis C into a real virus. Annu Rev Microbiol 2011; 65: 307-327.
9. Watson PJ, Roulois AJ, Scase TJ, Irvine R, Herrtage ME,. Prevalence of hepatic lesions at post-mortem examination in dogs and association with pancreatitis. J Small Anim Prac 2010; 51 (11): 566-572.
10. Bexfield NH, Andres-Abdo C, Scase TJ, Constantino-Casas F, Watson PJ,. Chronic hepatitis in the English springer spaniel: clinical presentation, histological description and outcome. Vet Rec 2011; 169 (16): 415. doi: 10.1136/vr.d4665.
11. Boomkens SY, Slump E, Egberink HF, Rothuizen J, Penning LC,. PCR screening for candidate etiological agents of canine hepatitis. Vet Microbiol 2005; 108 (1-2): 49-55.
12. Bateman AC,. Patterns of histological change in liver disease: my approach to 'medical' liver biopsy reporting. Histopathology 2007; 51 (5): 585-596.
13. Ishak KG,. Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol 2000; 113 (1): 40-55.
14. Van den Ingh TSGAM, Van Winkle TJ, Cullen JM, Charles JA, Desmet VJ,. Morphological classification of parenchymal disorders of the canine and feline liver: 2 Hepatocellular death, hepatitis and cirrhosis. In:, Rothuizen J, Bunch SE, Charles JA, et al. eds. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease, 1 edn. Philadelphia, PA: Saunders Elsevier, 2006: 85-102.
15. Guido M, Mangia A, Faa G,. Chronic viral hepatitis: the histology report. Dig Liver Dis 2011; 43 (Suppl 4): S331-S343.
16. Burbelo PD, Dubovi EJ, Simmonds P, et al,. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol 2012; 86 (11): 6171-6178.
17. Burbelo PD, Ching KH, Bren KE, Iadarola MJ,. Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems. Expert Rev Proteomics 2011; 8 (3): 309-316.
18. Burbelo PD, Goldman R, Mattson TL,. A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol 2005; 5: 22.
19. Burbelo PD, Ching KH, Klimavicz CM, Iadarola MJ,. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp 2009; (32): pii. 1549.
20. Burbelo PD, Bren KE, Ching KH, et al,. LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV. HIV and EBV. Mol BioSyst 2011; 7 (5): 1453-1462.
21. Burbelo PD, Ching KH, Mattson TL, Light JS, Bishop LR, Kovacs JA,. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). Biochem Biophys Res Commun 2007; 352 (4): 889-895.
22. Poldervaart JH, Favier RP, Penning LC, van den Ingh TS, Rothuizen J,. Primary hepatitis in dogs: a retrospective review (2002-2006). J Vet Intern Med 2009; 23 (1): 72-80.
23. Watson PJ,. Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. Vet J 2004; 167 (3): 228-241.
24. Jarrett WF, O'Neil BW,. A new transmissible agent causing acute hepatitis, chronic hepatitis and cirrhosis in dogs. Vet Rec 1985; 116 (24): 629-635.
25. Jarrett WF, O'Neil BW, Lindholm I,. Persistent hepatitis and chronic fibrosis induced by canine acidophil cell hepatitis virus. Vet Rec 1987; 120 (10): 234-235.
26. Chouinard L, Martineau D, Forget C, Girard C,. Use of polymerase chain reaction and immunohistochemistry for detection of canine adenovirus type 1 in formalin-fixed, paraffin-embedded liver of dogs with chronic hepatitis or cirrhosis. J Vet Diagn Invest 1998; 10 (4): 320-325.
27. Rakich PM, Prasse KW, Lukert PD, Cornelius LM,. Immunohistochemical detection of canine adenovirus in paraffin sections of liver. Vet Pathol 1986; 23 (4): 478-484.
28. Simons JN, Leary TP, Dawson GJ, et al,. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1 (6): 564-569.
29. Bexfield N, Kellam P,. Metagenomics and the molecular identification of novel viruses. Vet J 2011; 190 (2): 191-198.
30. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM,. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997; 277 (5325): 570-574.
31. Yanagi M, Purcell RH, Emerson SU, Bukh J,. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A 1997; 94 (16): 8738-8743.
32. Adinolfi LE, Andreana A, Utili R, Zampino R, Ragone E, Ruggiero G,. HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury. Am J Gastroenterol 1998; 93 (11): 2162-2166.
33. Coelho-Little E, Jeffers LJ, Bartholomew M, Reddy KR, Schiff ER, Dailey PJ,. Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C. J Hepatol 1995; 22 (2): 248-249.
34. Gordon SC, Kodali VP, Silverman AL, et al,. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 1994; 89 (9): 1458-1461.
35. Terrault NA, Dailey PJ, Ferrell L, et al,. Hepatitis C virus: quantitation and distribution in liver. J Med Virol 1997; 51 (3): 217-224.
36. White PA, Pan Y, Freeman AJ, et al,. Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR. J Clin Microbiol 2002; 40 (11): 4346-4348.
37. McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW,. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996; 23 (4): 676-687.
38. Burbelo PD, Kovacs JA, Ching KH, et al,. Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients. J Infect Dis 2010; 202 (6): 894-898.
39. Jangra RK, Yi M, Lemon SM,. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 2010; 84 (13): 6615-6625.
40. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309 (5740): 1577-1581.